Repligen (RGEN) Total Liabilities (2010 - 2026)

Repligen (RGEN) has 17 years of Total Liabilities data on file, last reported at $825.3 million in Q1 2026.

• Quarterly Total Liabilities fell 4.77% year-over-year to $825.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $825.3 million (down 4.77% YoY) and the FY2025 annual result came in at $843.6 million, down 1.56% from the prior year.
• Total Liabilities retreated to $825.3 million in Q1 2026 per RGEN's latest filing, from $843.6 million in the prior quarter.
• Across five years, Total Liabilities topped out at $888.1 million in Q1 2024 and bottomed at $549.0 million in Q3 2023.
• The 5-year median for Total Liabilities is $825.3 million (2026), against an average of $752.9 million.
• The widest annual swing landed in 2022, when Total Liabilities soared 66.37%; it then fell 12.5% in 2023.
• Tracing RGEN's Total Liabilities over 5 years: stood at $620.9 million in 2022, then jumped by 39.53% to $866.3 million in 2023, then fell by 1.08% to $856.9 million in 2024, then dropped by 1.56% to $843.6 million in 2025, then declined by 2.16% to $825.3 million in 2026.
• Per Business Quant, the three latest RGEN Total Liabilities figures stand at $825.3 million (Q1 2026), $843.6 million (Q4 2025), and $840.6 million (Q3 2025).

Peer Comparison